Prasugrel in critically ill patients

While prasugrel is indicated for the treatment of myocardial infarction, its effects in the most severely affected patients requiring intensive care is unknown, so that we measured the antiplatelet effects and sparse pharmacokinetics of prasugrel in critically ill patients. Twenty-three patients adm...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Thromb Haemost
Main Authors: Schoergenhofer, Christian, Hobl, Eva-Luise, Staudinger, Thomas, Speidl, Walter S., Heinz, Gottfried, Siller-Matula, Jolanta, Zauner, Christian, Reiter, Birgit, Kubica, Jacek, Jilma, Bernd
Format: Artigo
Jezik:Inglês
Izdano: Schattauer GmbH 2017
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6292180/
https://ncbi.nlm.nih.gov/pubmed/28692105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1160/TH17-03-0154
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki